Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

65.90 USD -2.09 (-3.07%)
Official Closing Price Updated: 4:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Arena Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Arena Pharmaceuticals Shows Rising Price Performance With Jump To 81 RS Rating
A Relative Strength Rating upgrade for Arena Pharmaceuticals shows improving technical performance. 
From Investor's Business Daily
Arena Pharmaceuticals Shows Rising Price Performance With Jump To 81 RS Rating
Arena Pharmaceuticals sees its Relative Strength Rating hit the 80-plus level. 
From Investor's Business Daily
A Cannabis ETF Looking For Redemption
Cannabis stocks and exchange traded funds endured a summer of woe. The actively managed AdvisorShares Pure Cannabis ETF (NYSE: YOLO) is ... 
Tags SNDL ARNA ETFs
From Benzinga
First Week of ARNA April 2020 Options Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available this week, for the April 2020 expiration. One of the key data points that goes into the price an option buyer is willing... 
Tags Stocks
From Market News Video
Arena Pharmaceuticals Clears Technical Benchmark, Hitting 80-Plus RS Rating
Arena Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Cidara Therapeutics, Inc. (NASDAQ: CDTX) shares rose 82.1% to $3.06 in pre-market trading after the company announced it ... 
Tags ZEAL News General
From Benzinga
Cannabis Central: How Much Of A Pure Play Is The Pure Cannabis ETF?
The AdvisorShares Pure Cannabis ETF debuted this past May as an actively “pure” fund of 28 constituents. Just how pure are the constituents? 
Tags Pharma/Biotech Healthcare ETFs
From Blogs - TalkMarkets
Stocks Showing Market Leadership: Arena Pharmaceuticals Earns 93 RS Rating
Arena Pharmaceuticals sees its Relative Strength Rating reach the elite 90-plus level. 
From Investor's Business Daily
We Did The Math PWC Can Go To $106
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting ARNA Put And Call Options For September 27th
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available today, for the September 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Noteworthy Thursday Option Activity: ARNA, TWLO, AVLR
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arena Pharmaceuticals Inc (ARNA), where a total volume of 2,848 contracts has been... 
Tags Stocks
From Market News Video
This Biotech Crashed Before Trading Halted — Plus 2 Stocks That Diverged
Investors punished biotech companies Sarepta Therapeutics and Arena Pharmaceuticals on growing losses in the second quarter, and lauded Aerie Pharmaceuticals for its guidance cut. 
From Investor's Business Daily
Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript
ARNA earnings call for the period ending June 30, 2019. 
Tags ARNA Market News
From Motley Fool
42 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers Tyme Technologies, Inc. (NASDAQ: TYME) stock moved upwards by 25.0% to $1.25 during Wednesday's after-market ... 
Tags DERM SRPT CLSD
From Benzinga
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags OBSV Biotech MGEN
From Benzinga
Strange: Bullish ARNA Analysts Actually See -3.78% Downside
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Arena Pharmaceuticals Inc (ARNA). The average 12-month price target for ARNA — averaging... 
Tags ETFs
From ETF Channel
First Week of ARNA September 20th Options Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available this week, for the September 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Stocks That Broke Yearly Highs Thursday Morning
On Thursday morning, 137 companies achieved new highs for the year. Noteworthy Mentions: adidas (OTC: ADDYY) ... 
Tags GM SLRK TSCRF
From Benzinga
Stocks That Managed to Breach 52-Week Highs Wednesday Morning
During Wednesday's morning trading, 220 companies set new 52-week highs. Highlights: Nestle (OTC: ... 
Tags SF ACOPF AWR
From Benzinga
40 Healthcare Stocks Moving In Friday's After-Market Session
Gainers Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) stock increased by 10.2% to $1.30 during Friday's after-market session. ... 
Tags SLS TTNP FGEN
From Benzinga
The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight
The following is a roundup of the top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ... 
Tags FDA FATE ARNA
From Benzinga
ARNA Crosses Above Average Analyst Target
In recent trading, shares of Arena Pharmaceuticals Inc (ARNA) have crossed above the average analyst 12-month target price of $60.00, changing hands for $60.69/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags HTGM Market News Pre/Market Outlook
From Benzinga
Arena Pharmaceuticals Earns Membership In 95-Plus Composite Rating Club
On Tuesday, Arena Pharmaceuticals got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. 
From Investor's Business Daily
ARNA August 2nd Options Begin Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available today, for the August 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Here's Why United Therapeutics Fell 18.1% in May
The stock has now fallen nearly 30% since the end of March. 
Tags Market News ARNA UTHR
From Motley Fool
3 Promising Gene Therapy Stocks
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies. 
Tags Pharma/Biotech
From Blogs - TalkMarkets
Jim Cramer Shares His Thoughts On Arena Pharmaceuticals, Yext And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is a speculative stock, ... 
Tags CC Jim Cramer ARNA
From Benzinga
Notable Thursday Option Activity: ARNA, BG, KNX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Arena Pharmaceuticals Inc (ARNA), where a total of 3,143 contracts have traded so far,... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags DMPI Trading Ideas Offerings
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback